[Clinical use of phospholipids from bovine brains in patients with cerebrovascular disorders and syndromes following commotio and contusio cerebri].
D000284:Administration, Oral; D000328:Adult; D000818:Animals; D001924:Brain Concussion / Q000150:complications*; D001930:Brain Injuries / Q000150:complications*; D002417:Cattle; D002561:Cerebrovascular Disorders / Q000150:complications*; D004569:Electroencephalography; D005260:Female; D006801:Humans; D008297:Male; D001523:Mental Disorders / Q000188:drug therapy / Q000209:etiology; D019965:Neurocognitive Disorders / Q000188:drug therapy*; D009461:Neurologic Manifestations; D010743:Phospholipids / Q000627:therapeutic use*; D011581:Psychological Tests; D011602:Psychophysiologic Disorders / Q000188:drug therapy / Q000209:etiology; D013577:Syndrome; D014020:Tissue Extracts
D010743:Phospholipids; D014020:Tissue Extracts
Klinische Anwendung von Phospholipiden aus Rinderhirn bei Mangeldurchblutung des Gehirns und Syndrom nach Commotio und Contusio cerebri.